Alcohol Brand Restructuring and New Category Development Framework
Creating the reasons to drink once again: A practical guide to brand reconstruction by customer segment and new category development.
We provide a practical framework for liquor manufacturers to redesign the "reasons to drink" for each customer segment, facilitating brand reconstruction and the development of new categories. As per capita alcohol consumption has decreased by 25% from its peak, we support responses to younger consumers, health-conscious individuals, and craft-oriented groups, as well as expansion into the low-alcohol and non-alcohol markets. We offer a complimentary brand diagnosis, so please feel free to contact us.
basic information
【Specifications】 - Alcohol brand reconstruction four-layer framework (customer segment analysis, experience communication, product category development, brand portfolio) - Redesigned approach to "reasons for drinking" by customer segment - Three-step execution roadmap for brand reconstruction - Comparison framework of traditional brand strategy and the desired future state - Self-diagnosis check for alcohol brand fit - Brand diagnosis (free of charge) provided
Price range
Delivery Time
Applications/Examples of results
【Applications and Achievements】 - Brand strategy planning for alcoholic beverage manufacturers targeting younger and health-conscious consumers - Development of new categories for low-alcohol and non-alcohol products - Portfolio design and investment allocation optimization for existing and new brands - Planning of marketing measures based on customer segment analysis for different drinking scenarios - Design of customer acquisition strategies utilizing experiential events and social media - Restructuring of business strategy in light of the 2026 unification of beer-related alcohol taxes
catalog（1）
Download All Catalogs
Recommended products
Distributors
Accenture transforms change into power, providing 360-degree value to customers, employees, shareholders, partner companies, and society. We support Bristol Myers Squibb by leveraging generative AI and automation to accelerate clinical trials and streamline drug development. We consolidate our full capabilities as a reinvention service to solve the most challenging problems. We guide enterprise transformation to be executed on a larger scale and with greater impact.